title: Pregnancy in antiphospholipid syndrome: can we improve patient management?
authors.forename: Cecilia
authors.initials: C
authors.lastname: Nalli
authors.forename: Angela
authors.initials: A
authors.lastname: Tincani
mesh_terms: D000026:Abortion, Habitual / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000276:immunology / Q000628:therapy; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D019468:Disease Management; D005260:Female; D005313:Fetal Death / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D056747:Immunomodulation; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology / Q000517:prevention & control; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D018570:Risk Assessment; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D018501:Antirheumatic Agents